Articles dans des revues avec comité de lecture (11)
  1. 1. Pirson, M., Brauner, J., Byl, B., Demeester, R., Yin, N., Vincent, M., Leclercq, P., & Vandenberg, O. (2025). Comparaison du coût et de la durée de séjour des bactériémies nosocomiales dues aux bactéries multirésistantes. Une première approche pour évaluer le bénéfice potentiel de la phagothérapie d’un point de vue pharmaco-économique. Revue médicale de Bruxelles,(46), 552-559.
  2. 2. Pirson, M., Marbaix, S., Bruyneel, A., Leclercq, P., van den bulcke, J., & Brauner, J. (2024). Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings. Vaccine. doi:https://doi.org/10.1016/j.vaccine.2024.03.057
  3. 3. Moerman, A., Vernelen, K., China, B., Capron, A., Bossche, D. V. D., Mariën, J., Ariën, K., Van Acker, J., Delforge, M.-L., Reynders, M., Boel, A., Depypere, M., van Gasse, N., Vijgen, S., Brauner, J., Dujardin, B., & Padalko, E. (2022). Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme. Diagnostic microbiology and infectious disease, 102(2), 115561. doi:10.1016/j.diagmicrobio.2021.115561
  4. 4. Fattorutto, M., Bouckaert, Y., Brauner, J., Franck, S., Bouton, F., Heuse, D., Bouckaert, C., & Bruyneel, A. (2021). Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS‑COV‑2 infection. Journal of thrombosis and thrombolysis, 1-9. doi:https://doi.org/10.1007/s11239-021-02514-3
  5. 5. Ocmant, A., Roisin, S., De Meuter, R., & Brauner, J. (2021). Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics. Journal of medical virology, 93(5), 2583-2584. doi:10.1002/jmv.26800
  6. 6. Favresse, J., Brauner, J., Bodart, N., Vigneron, A., Roisin, S., Melchionda, S., Douxfils, J., & Ocmant, A. (2020). An original multiplex method to assess five different SARS-CoV-2 antibodies. Clinical chemistry and laboratory medicine. doi:10.1515/cclm-2020-1652
  7. 7. Lecordier, L., Uzureau, P., Tebabi, P., Brauner, J., Benghiat, F., Vanhollebeke, B., & Pays, E. (2015). Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus. Molecular microbiology. doi:10.1111/mmi.13036
  8. 8. Claes, G., Bron, D., Maerevoet, M., Benghiat, F., De Wilde, V., Bailly, B., Istaces, N., Brauner, J., Pradier, O., & Meuleman, N. (2015). P1.14 MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL): RESULTS OF A ROUTINE SCREENING IN A GENERAL HOSPITAL. Belgian Journal of Hematology, 18.
  9. 9. Brauner, J., Hallin, M., Deplano, A., De Mendonça, R., Nonhoff, C., De Ryck, R., Roisin, S., Struelens, M., & Denis, O. (2012). Community-acquired methicillin-resistant Staphylococcus aureus clones circulating in Belgium from 2005 to 2009: changing epidemiology. European journal of clinical microbiology & infectious diseases, 32(5), 613-620. doi:10.1007/s10096-012-1784-6
  10. 10. Wolff, F., Debaugnies, F., Rozen, L., Willems, D., Brohet, F., Brauner, J., & Stordeur, P. (2012). Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy. Clinical biochemistry, 46(1-2), 79-84. doi:10.1016/j.clinbiochem.2012.09.023
  11. 11. Vergison, A., Nobre Machado, A., Deplano, A., Doyen, M., Brauner, J., Nonhoff, C., De Mendonça, R., Mascart, G., & Denis, O. (2012). Heterogeneity of disease and clones of community-onset methicillin-resistant Staphylococcus aureus in children attending a paediatric hospital in Belgium. Clinical microbiology and infection. doi:10.1111/j.1469-0691.2011.03637.x
    12.   Participations à des congrès et colloques internationaux (3)
  12. 1. Brauner, J., Beukinga, I., Penninck, D., Kassengera, Z., & Pradier, O. (2012). HematoFlow and Cytodiff: Rethinking the hematology laboratory - 18 months experience in a middle sized teaching hospital. Poster présenté à la conférence XXVth International Symposium on Technological Innovations in Laboratory Hematology (25: May 21-23 2012: Nice, France).
    13. << Précédent 1 2 Suivant >>